Related Experiment Videos
Laser surgery for transitional-cell carcinoma. Technique, advantages, and limitations.
1Department of Urology, Vanderbilt University School of Medicine, Nashville, Tennessee.
The Urologic Clinics of North America
|August 11, 1992
Summary
Laser therapy effectively eradicates visible superficial bladder tumors without bleeding, offering advantages over electrocautery. While not decreasing recurrence rates, laser treatment provides a valuable option for managing transitional-cell carcinoma of the bladder.
Area of Science:
- Urology
- Oncology
- Surgical Technology
Background:
- Lasers offer unique tissue effects distinct from electrocautery.
- Superficial bladder cancer management requires effective and safe treatment modalities.
Purpose of the Study:
- To evaluate the efficacy and safety of laser therapy for superficial transitional-cell carcinoma of the bladder.
- To compare laser treatment with electrocautery in bladder cancer management.
Main Methods:
- Noncontact coagulation necrosis achieved via laser energy.
- Endoscopic application using flexible cystoscopes and fibers.
- Assessment of tumor eradication, bleeding, complications, and potential for adjuvant chemotherapy.
Main Results:
- Effective eradication of grossly visible superficial bladder tumors.
- No intraoperative bleeding observed, unlike electrocautery.
- Rare complications including bowel injury; bladder perforation and nerve stimulation are unlikely.
- Potential for earlier adjuvant intravesical chemotherapy post-treatment.
Conclusions:
- Laser therapy is effective for eradicating superficial bladder tumors, with significant advantages over electrocautery.
- While recurrence rate data are insufficient, laser treatment has an established role in bladder cancer management.
- Patient selection and appropriate safety measures, including eye protection, are crucial for optimal outcomes.